Società Nextage Therapeutics Ltd TEL AVIV STOCK EXCHANGE
Azioni
NXTG
IL0004330119
Biotecnologia
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Abraham Dreazen
CEO | Chief Executive Officer | 40 | 12/08/20 |
Ishai Gandelsman
DFI | Director of Finance/CFO | 61 | 10/07/22 |
General Counsel | 53 | 12/08/20 | |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 70 | 01/01/94 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Yaacov Elinav
BRD | Director/Board Member | 79 | 12/08/20 |
Israel Makov
CHM | Chairman | 85 | 21/11/11 |
Ron Grupel
BRD | Director/Board Member | 74 | 13/10/14 |
Jakob Ripshtein
BRD | Director/Board Member | 57 | 12/08/20 |
Orna Dreazen
BRD | Director/Board Member | 69 | 12/08/20 |
Director/Board Member | 59 | 12/08/20 | |
Director/Board Member | 72 | 12/08/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 33 268 639 | 5 155 250 ( 15,50 %) | 0 | 15,50 % |
Coordinate società
NEXTAGE Therapeutics Ltd.
Einstein Street, Building 13B Weizmann Science Park
7403617, Ness Ziona
+
http://www.nxtg.co.ilSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
-37,33% | 8,27 Mrd | |
+14,86% | 3,67 Mrd | |
+7,38% | 2,36 Mrd | |
-25,96% | 1,87 Mrd | |
-17,30% | 1,73 Mrd | |
+36,49% | 1,14 Mrd | |
+32,58% | 823 Mln | |
-7,64% | 678 Mln | |
-18,37% | 573 Mln |